We are live on ! Find out more
PAI

Palo Alto Investors Portfolio holdings

AUM $654M
1-Year Est. Return 77.8%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+77.8%
3 Year Est. Return
+127.05%
5 Year Est. Return
+199.24%
10 Year Est. Return
+2,229.57%
AUM
$847M
AUM Growth
–
Cap. Flow
+$832M
Cap. Flow %
98.22%
Top 10 Hldgs %
74.89%
Holding
32
New
32
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$122M
2
VPHM
VIROPHARMA INC
VPHM
+$105M
3
CYBX
CYBERONICS INC
CYBX
+$88.3M
4
UTHR icon
United Therapeutics
UTHR
+$58M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$49.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 34.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPPI
26
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2.95M 0.35%
+395,985
New +$3.04M
KYTH
27
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$2.33M 0.28%
+86,201
New +$1.97M
XOMA
28
DELISTED
Xoma
XOMA
$1.9M 0.22%
+26,134
New +$1.95M
HPTX
29
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.84M 0.22%
+83,600
New +$1.83M
PRTA icon
30
Prothena Corp
PRTA
$470M
$1.14M 0.13%
+88,500
New +$823K
DNDN
31
DELISTED
DENDREON CORPORATION
DNDN
$856K 0.1%
+207,800
New +$884K
NXTM
32
DELISTED
NxStage Medical Inc.
NXTM
$630K 0.07%
+44,129
New +$555K
1
2

Similar funds

RRA
Round Rock Advisors Wilton, Connecticut $654M AUM 22.95% 1-Year Est. Return
AG
Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return
BL
BWCP LP Dallas, Texas $656M AUM 41.58% 1-Year Est. Return
PIM
Parker Investment Management Menlo Park, California $659M AUM 52.52% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return
HCM
Huber Capital Management El Segundo, California $647M AUM 24.91% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return

Palo Alto Investors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Palo Alto Investors, which disclosed 32 positions worth $847M. Its ten largest holdings account for 75% of the portfolio.

Its largest position is ONYX PHARMACEUTICALS INC: 1,325,115 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets.

  • Palo Alto Investors's largest Q2 2013 buy was ONYX PHARMACEUTICALS INC: 1,325,115 shares worth $115M.
  • Palo Alto Investors's ten largest holdings make up 75% of its $847M portfolio in Q2 2013.
  • Palo Alto Investors disclosed 32 positions in Q2 2013, its first 13F filing on record.

Based on Palo Alto Investors's 13F filing for Q2 2013, filed 14 Aug 2013.